Company / Free Cash Flow
ARVINAS, INC. Free Cash Flow History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$275.7M
FY2025
5-year range
-$350.7M / -$46.9M
FY2021-FY2025
Trend
-5.6%
vs FY2024
Sector context
#164 of 194
Health Care
What the data says
ARVINAS, INC.'s free cash flow of -$276M is lower than 85% of companies in the Health Care sector (FY2025). Free Cash Flow has fluctuated over the past 9 years, ranging from -$351M in FY2023 to $4M in FY2017.
Based on SEC 10-K filings.
-$276M in FY2025.
Improved from -$351M to -$276M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 194This company -$275.7M Sector average $470.6M
▼
-158.6% below sector average
Key checks
Key Insights
- In FY2025, free cash flow decreased 5.6% year-over-year.
- Ranks #164 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2017.
- Lowest free cash flow in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.85 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$275.7M | -5.6% |
| FY2024 | -$261.1M | +25.5% |
| FY2023 | -$350.7M | -264.9% |
| FY2022 | -$96.1M | -104.9% |
| FY2021 | -$46.9M | +51.2% |
| FY2020 | -$96.1M | -407.2% |
| FY2019 | -$18.9M | +0.0% |
| FY2018 | -$18.9M | -562.1% |
| FY2017 | $4.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026